Advertisement

Topics

Impax Laboratories, Inc. (IPXL) Price Target Raised to $35.00

23:11 EST 13 Nov 2017 | Topix

They currently have an overweight rating on the specialty pharmaceutical company's stock. A number of other equities analysts have also weighed in on the company.

Original Article: Impax Laboratories, Inc. (IPXL) Price Target Raised to $35.00

NEXT ARTICLE

More From BioPortfolio on "Impax Laboratories, Inc. (IPXL) Price Target Raised to $35.00"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Obesity
Obesity is the condition in which excess fat has accumulated in the body (mostly in subcutaneous tissues). clinical obesity is considered to be present when a person has a BMI of over 30 (Oxford Dictionary of Medicine). It is becoming increasing common i...